§ BIOTECHNOLOGY
USD · Biotechnology

TVTX

TRAVERE THERAPEUTICS INC
USDSector · BiotechnologyBeta · 1.06
LAST
n/a
n/aPREV CLOSE · n/a
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX

§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY

13F FLOW
213 increased/new, 96 decreased/exited (13F)
AC 13F Analysis

§ 04 · FUNDAMENTALS · THE BOOKS

P/B29.77EPS (TTM)-0.33
§ 05 · WHO OWNS IT
Top institutional holders
All holders →
FundShares% portΔ Q/Q
JANUS HENDERSON GROUP PLC11.4Mn/a+9%
Fidelity Management11.0M0.0%+14%
BlackRock, Inc.7.8M0.0%−1%
State Street5.0M0.0%+4%
ARMISTICE CAPITAL, LLC4.9M2.6%+30%
PERCEPTIVE ADVISORS LLC4.1Mn/a−3%
◇ AC INTELLIGENCE

Top institutional owners for TVTX as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.

§ 06 · WHO OWNS IT · BY STRATEGY

OTHER96.6% · 0 holders
OTHER1.5% · 184 holders
QUALITY / COMPOUNDER1.0% · 20 holders
DEALER / BANK0.3% · 25 holders
PASSIVE / INDEX0.3% · 9 holders
SYSTEMATIC / QUANT0.1% · 10 holders
INCOME / DEFENSIVE0.0% · 14 holders
ACTIVIST0.0% · 1 holder
TACTICAL / MACRO0.0% · 4 holders
GROWTH / MOMENTUM0.0% · 1 holder
◇ AC INTELLIGENCE

Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.

§ 07 · INSIDER ACTIVITY · LAST 180 DAYS

NO INSIDER FILINGS
◇ AC INTELLIGENCE

No Form 4 filings on record for TVTX in the last 180 days.

§ 08 · COVERAGE · OUR RECENT NOTES

No notes mention TVTX yet.